4Level C, Chauveau P, Guisset O, et al. Mass tuansfer, clearance and plasma concentration of procalcitonin during continuous veno- venous hemofiltration in patients with septic shock and acute oli gUric renal failure[J]. Crit Care, 2003,7(6) ~ R160-165.
5Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation,infection, and sepsis~ clinical utility and limitations [J]. Crit Care Med,2008,36(3):941-952.
6Lee JY, Hwang SJ, Shim JW, et al. Clinical significance of serum procalcitonin in patients with communlty'acquired lobar pneumo nia[J]. Korean J Lab Med,2010,30(4) :406-413.
7Hur M, Moon HW, Yun YM, et al. Comparison of diagnostic utili ty between procalcitonin and C-reactive protein for the patients with blood culture-positive sepsis[J]. Korean J Lab Med, 2009,29 (6) :529-535.
8Sehuetz P, Mueller B, Trampuz A. Serum procalcitonin for dis- crimination of blood contamination from bloodstream infection due to coagulase negative staphylococci [J]. Infection, 2007, 35 (5):352-355.
9Korczowski B,Szybist W. Serum procalcitonin and C-reactive pro- tein in children with diarrhoea of various aetiologies[J]. Acta Pae- diatr, 2004,93 (2) : 169-173.
